---
title: "Finvi Sells Artiva HCx Business to VisiQuate to Focus on Collections Market"
description: "Finvi has sold its Artiva HCx business to VisiQuate, a healthcare revenue cycle technology company, according to a company announcement. The deal, announced on November 4, 2026, will allow Finvi to sharpen its focus on the collections market, the company said in a LinkedIn post. Financial terms of the acquisition were not disclosed, according to a press release."
canonical_url: https://clinicalterminal.com/article/107785713
section: funding-and-ma
byline: Victoria Shi · AI Funding Reporter
date_published: 2026-11-09T18:56:19.628Z
date_label: November 9, 2026
image: https://firebasestorage.googleapis.com/v0/b/clinical-ai-design.firebasestorage.app/o/desk-heroes%2Ffe_tCkgtTZnmtptKPb2iU8V%2Fhero_82d36f41be86_w1920.jpg?alt=media
source: https://clinicalterminal.com
---

# Finvi Sells Artiva HCx Business to VisiQuate to Focus on Collections Market

*[Finvi](https://app.clinicalterminal.com/company/100923712) has sold its Artiva HCx business to [VisiQuate](https://app.clinicalterminal.com/company/101517995), a healthcare revenue cycle technology company, according to a company announcement. The deal, announced on November 4, 2026, will allow Finvi to sharpen its focus on the collections market, the company said in a LinkedIn post. Financial terms of the acquisition were not disclosed, according to a press release.* [1, 3]

The sale includes the Artiva HCx revenue cycle workflow platform, the team responsible for it, and its existing clients, VisiQuate reported. The platform is used to manage insurance follow-ups, denial management, and collections. Clinical Terminal data shows that UC Health has used Finvi’s Artiva HCx solution to manage its patient-pay portfolio. [2, 5]

Finvi, formerly known as Ontario Systems, provides technology to clients in healthcare and accounts receivable to help strengthen revenue recovery, according to company records. VisiQuate specializes in healthcare revenue cycle intelligence and automation.

Finvi stated that the divestiture allows it to concentrate resources and investments on AI-first solutions for its accounts receivable management customers. The company has served the third-party collections market for nearly five decades, according to its website. For VisiQuate, the acquisition is part of a growth strategy supported by a 2024 partnership with technology investment firm [Accel-KKR](https://app.clinicalterminal.com/company/107785711), according to reports. [1, 2, 4]

"Every revenue cycle problem worth solving takes deep expertise, and we just added a lot of it," VisiQuate's Chief Strategy Officer, [Derek Foster](https://app.clinicalterminal.com/person/200930), said in a statement. [2]

Both companies said they will collaborate to support customers through the transition and that existing contracts will be honored. According to VisiQuate, Artiva HCx customers will gain access to its reporting, intelligence, and automation capabilities. [1, 2]

## Sources

1. [LinkedIn post by Finvi](https://www.linkedin.com/posts/finvi_today-finvi-announced-the-sale-of-its-artiva-activity-7523738351791951873-ZXOR) — Today, Finvi announced the sale of its Artiva HCx business to VisiQuate, a healthcare revenue cycle ...
2. [visiquate.com](https://www.visiquate.com/news/visiquate-acquires-artiva-hcx) — VisiQuate Acquires Artiva HCx, Uniting Revenue Cycle Intelligence and Workflow Expertise to Turn Insight Into Action // VisiQuate News
3. [PR Newswire](https://www.prnewswire.com/news-releases/finvi-sells-artiva-hcx-business-to-visiquate-sharpening-focus-on-collections-market-302928157.html) — Finvi Sells Artiva HCx Business to VisiQuate, Sharpening Focus on Collections Market, 2026-11-04
4. [Finvi](https://finvi.com/event/aaham-2026-annual-national-institute/) — Artiva HCx is now part of VisiQuate, 2026-08-20
5. Clinical Terminal data

---
Canonical article: https://clinicalterminal.com/article/107785713  
Entity profiles referenced above resolve to https://app.clinicalterminal.com.
